Skip to main content
NIH funding notice RFA-DK-22-009

Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed)

Closed on October 26, 2022.

Posted
July 13, 2022
Close date
October 26, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,468,842 in first-year total cost, median $943,657.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-9 (M3)]3

Most frequent institutions

  1. BROAD INSTITUTE, INC.1
  2. STANFORD UNIVERSITY1
  3. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
Competing awards under RFA-DK-22-009 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023iSTAR Tregs1U01DK137140-01MCMANUS, MICHAEL TPARENT, AUDREYTANG, QIZHIUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$969,000ZDK1
2023Development of platforms for beta cell-specific delivery and ligand discovery1U01DK137242-01CHOUDHARY, AMITKULKARNI, ROHIT N.BROAD INSTITUTE, INC., MA$943,657ZDK1
2023Developing A Platform Technology For β-Cell-Targeted Drug Delivery1U01DK136965-01ANNES, JUSTIN PIERCESTANFORD UNIVERSITY, CA$556,185ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DK-22-009: Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience